/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Immunovant Inc Share Price Today: Live Updates & Key Insights

Immunovant Inc share price today is $22.7136, up -2.83%. The stock opened at $23.64 against the previous close of $23.65, with an intraday high of $23.92 and low of $22.8.

Immunovant Inc Share Price Chart

style
pb-0

Immunovant Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Immunovant Inc Share Price Performance

$22.7136 -0.0283(-2.83%) IMVT at 23 Mar 2026 01:39 PM Biotechnology
Lowest Today 22.8
Highest Today 23.92
Today’s Open 23.64
Prev. Close 23.65
52 Week High 29.25
52 Week Low 12.72
Day’s Range: Low 22.8 High 23.92
52-Week Range: Low 12.72 High 29.25
1 day return -
1 Week return -7.96
1 month return -15.34
3 month return -16.43
6 month return +47.62
1 year return +18.25
3 year return +44.6
5 year return +33.95
10 year return -

Immunovant Inc Institutional Holdings

FMR Inc 8.35

Deep Track Capital, LP 4.78

Vanguard Group Inc 3.82

Fidelity Growth Compy Commingled Pl S 3.35

Armistice Capital, LLC 2.82

BlackRock Inc 2.82

Baker Bros Advisors LP 2.68

T. Rowe Price Investment Management,Inc. 2.54

Fidelity Growth Company Fund 2.47

Point72 Asset Management, L.P. 1.69

RTW INVESTMENTS, LLC 1.56

State Street Corp 1.42

Two Seas Capital LP 1.41

Alpine Partners VI, LLC 1.29

Vanguard Total Stock Mkt Idx Inv 1.26

ADAR1 Capital Management LLC 1.22

State Street® SPDR® S&P® Biotech ETF 1.09

Woodline Partners LP 0.97

Morgan Stanley - Brokerage Accounts 0.96

Geode Capital Management, LLC 0.91

Vanguard Small Cap Index 0.90

T. Rowe Price US Small-Cap Core Equity 0.85

T. Rowe Price Small-Cap Stock 0.84

iShares Russell 2000 ETF 0.84

Perceptive Advisors LLC 0.78

The Goldman Sachs Group Inc 0.73

Fidelity Growth Company K6 0.69

Aberdeen Group PLC 0.58

Fidelity Series Growth Company 0.55

Fidelity Contrafund 0.50

T. Rowe Price Instl Small-Cap Stock 0.48

T. Rowe Price U.S. SC Core Eq Tr-D 0.42

Adage Capital Partners Gp LLC 0.42

Vanguard Institutional Extnd Mkt Idx Tr 0.41

abrdn Healthcare Investors 0.36

Fidelity Small Cap Index 0.34

iShares Biotechnology ETF 0.31

Candriam Eqs L Biotech C USD Cap 0.30

Vanguard Small Cap Value Index Inv 0.29

iShares Russell 2000 Growth ETF 0.29

Immunovant Inc Market Status

Strong Buy: 10

Buy: 3

Hold: 1

Sell: 0

Strong Sell: 0

Immunovant Inc Fundamentals

Market Cap 4677.17 M

PB Ratio 4.8812

PE Ratio 0.0

Enterprise Value 4099.66 M

Total Assets 776.22 M

Volume 3885145

Immunovant Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-377000 -0.4M, FY24:-231000 -0.2M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-413840000 -413.8M, FY24:-259336000 -259.3M, FY23:-210960000 -211.0M, FY22:-156730000 -156.7M, FY21:-107431000 -107.4M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:160000 0.2M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:-101000 -0.1M, Q3/2025:-105000 -0.1M, Q2/2025:-107000 -0.1M, Q1/2025:80000 0.1M, Q4/2024:null 0.0M

Quarterly Net worth Q4/2025:-110635000 -110.6M, Q3/2025:-126502000 -126.5M, Q2/2025:-120613000 -120.6M, Q1/2025:-106449000 -106.4M, Q4/2024:-111122000 -111.1M

About Immunovant Inc & investment objective

Company Information Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Organisation Biotechnology

Employees 362

Industry Biotechnology

CEO Dr. Eric Venker M.D., Pharm.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Immunovant Inc FAQs

What is the share price of Immunovant Inc today?

The current share price of Immunovant Inc is $22.7136.

Can I buy Immunovant Inc shares in India?

Yes, Indian investors can buy Immunovant Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Immunovant Inc shares in India?

You can easily invest in Immunovant Inc shares from India by:

Can I buy fractional shares of Immunovant Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Immunovant Inc?

Immunovant Inc has a market cap of $4677.17 M.

In which sector does Immunovant Inc belong?

Immunovant Inc operates in the Biotechnology sector.

What documents are required to invest in Immunovant Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Immunovant Inc?

The PE ratio of Immunovant Inc is N/A and the PB ratio is 4.88.